Training Specialist, Cell Therapy Manufacturing in Devens, MA at Bristol-Myers Squibb

Devens, Massachusetts, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • 4+ years of experience in cGMP bioprocessing manufacturing, cell therapy manufacturing or relevant experience
  • Bachelor's in relevant science or engineering discipline, or equivalent in work experience
  • Knowledge of cGMP regulations and FDA guidance applicable to biologics and cell therapy manufacturing preferred
  • Experience with delivering training to adult learners and groups
  • Experience and knowledge of Cell Therapy operations preferred
  • Ability to gown into a cleanroom environment
  • Ability to be near strong magnets
  • Strong practical and theoretical knowledge in work
  • Communicates effectively between peers, trainees, and cross-functional stakeholders
  • Ability to work collaboratively with all employees at all levels
  • Demonstrates strong problem solving and critical thinking skills

Responsibilities

  • Demonstrates the ability to execute operations as described in standard operating procedures and batch records
  • Completes documentation required by training policies and standard operating procedures
  • Performs and demonstrates tasks in a manner consistent with the safety policies, quality systems, and GMP requirements
  • Qualifies new employees on assigned curriculum required of their job functions
  • Executes trainee requalifications as needed
  • On-time completion of training assignments to ensure technical skills and knowledge are adequate prior to the training of other individuals
  • Collaborates with support groups on recommendations and solving training gaps between new hire onboarding and the transition to manufacturing operations
  • Identifies innovative solutions
  • Supports creation of manufacturing training materials such as On-The-Job-Trainings and Instructor-Led-Trainings
  • Works independently and escalates issues appropriately, works with Management to resolve

Skills

GMP
Cell Therapy
Manufacturing
Training Delivery
Safety
Quality

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI